개인구독
소속 기관이 없으신 경우, 개인 정기구독을 하시면 저렴하게
논문을 무제한 열람 이용할 수 있어요.
지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2022.4
- 수록면
- 203 - 212 (10page)
이용수
초록· 키워드
오류제보하기
Background/Aims: Fecal S100A12 (FS) and serum S100A12 (SS) have been reported as novel biomarkers that accurately reflect intestinal inflammation. We evaluated if FS and SS in comparison to fecal calprotectin (FC) are associated with poor future outcomes in clinically quiescent Crohn’s disease (CD) patients. Methods: We prospectively enrolled 49 CD patients in clinical remission (Crohn’s Disease Activity Index [CDAI] <150 for the past 6 months). Patients were followed for a median period of 4.4 years (interquartile range [IQR], 4.3?4.5). The following outcomes were evaluated: clinical relapse, CD-related hospitalization, step-up of medical treatment, and CD-related intestinal resection. Cox proportional-hazard regression model was constructed to assess the association of baseline markers with time-to-event outcomes. Results: The median levels of baseline FS, FC, and SS were 0.042 mg/kg (IQR, 0.005?0.179), 486.8 mg/kg (IQR, 203.5?886.8) and 1,398.2 ng/mL (IQR, 791.8?2,759.9), respectively. FS correlated with FC (r=0.689), erythrocyte sedimentation rate (r=0.524), C-reactive protein (r=0.499), and albumin (r=?0.446), but not with CDAI (r=0.045). Interestingly, increased FS (top quartile) was associated with a 4.9-fold increased rate of future CD-related hospitalization (P=0.009) and a 2.8-fold increased rate of step-up of medical treatment (P=0.032), whereas increased FC and SS were not. These findings remained significant after adjusting for age, sex, disease duration, current smoking, C-reactive protein, serum albumin, CDAI, and FC, individually. Conclusions: In this pilot study, increased FS and not FC or SS, was significantly associated with increased rates of future CD-related hospitalization and step-up of medical treatment among CD patients in clinical remission.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Efficacy of Adalimumab in Korean Patients with Crohn’s Disease
Gut and Liver
2016 .01
-
Intestinal ultrasonography and fecal calprotectin for monitoring inflammation of ileal Crohn’s disease: two complementary tests
Intestinal research
2022 .07
-
Does fecal calprotectin equally and accurately measure disease activity in small bowel and large bowel Crohn’s disease?: a systematic review
Intestinal research
2019 .01
-
Exclusive enteral nutrition for induction of remission in anti-tumor necrosis factor refractory adult Crohn’s disease: the Indian experience
Intestinal research
2020 .01
-
Fecal Calprotectin at Postinduction Is Capable of Predicting Persistent Remission and Endoscopic Healing after 1 Year of Treatment with Infliximab in Pediatric Patients with Crohn’s Disease
Gut and Liver
2024 .05
-
Diagnostic Accuracy of Fecal Calprotectin for the Detection of Small Bowel Crohn's Disease through Capsule Endoscopy: An Updated Meta-Analysis and Systematic Review
Gut and Liver
2021 .09
-
Disease Phenotype, Activity and Clinical Course Prediction Based on C-Reactive Protein Levels at Diagnosis in Patients with Crohn’s Disease: Results from the CONNECT Study
Gut and Liver
2016 .01
-
Usefulness of C-Reactive Protein as a Disease Activity Marker in Crohn’s Disease according to the Location of Disease
Gut and Liver
2015 .01
-
Second Korean guidelines for the management of Crohn’s disease
Intestinal research
2017 .01
-
The role of fecal calprotectin in pediatric disease
Clinical and Experimental Pediatrics
2019 .01
-
Korean clinical practice guidelines on biologics for moderate to severe Crohn’s disease
Intestinal research
2023 .01
-
Effectiveness of transabdominal ultrasonography in predicting clinical relapse of Crohn’s disease
Intestinal research
2024 .01
-
Prediction of 12-Week Remission by Psychopharmacological Treatment Step in Patients With Depressive Disorders
PSYCHIATRY INVESTIGATION
2022 .10
-
Effect of resistance exercise training on Crohn’s disease patients
Intestinal research
2021 .01
-
Changes in serum levels of lipopolysaccharides and CD26 in patients with Crohn’s disease
Intestinal research
2017 .01
-
Umbilical Cord Mesenchymal Stem Cell Treatment for Crohn’s Disease: A Randomized Controlled Clinical Trial
Gut and Liver
2018 .01
-
Underestimation of Smoking Rates in an East Asian Population with Crohn’s Disease
Gut and Liver
2017 .01
-
Management of Crohn’s disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease
Intestinal research
2017 .01
-
한방치료로 관해가 유도된 소아 크론병 환자의 증례 보고
대한한방내과학회지
2021 .10
-
Surgery in Pediatric Crohn’s Disease: Indications, Timing and Post-Operative Management
Pediatric Gastroenterology, Hepatology & Nutrition
2017 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0